Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25